Search results
Results from the WOW.Com Content Network
It was the first time that the FDA had "taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse." [46] In 2021, New York Attorney General Letitia James filed a lawsuit against Endo and several other opioid manufacturers for their alleged contribution to the opioid epidemic in ...
Emergent BioSolutions, the manufacturer of the opioid overdose reversal drug, announced it would be providing a two-dose package for pharmacies nationwide starting in September, according to an ...
The law (TN Code 53-11-311) that prevents nurse practitioners (NPs) or physician assistants (PAs) from prescribing more than 16 milligrams of buprenorphine-naloxone daily (despite standard dosing ...
Tapentadol is a novel opioid that displays high affinity and selectivity for the μ-opioid receptor; In a human liability pharmacology study conducted by the sponsor, it was found that tapentadol displays a high abuse potential similar to hydromorphone , a controlled substance with a similar risk of abuse, misuse and diversion; and
This is a list of opioids, opioid antagonists and inverse agonists. ... Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; ...
Opioid overdose reversal drug Narcan will be available over the counter to buy at drug stores, supermarkets and convenience stores.
This is a list of investigational analgesics, or analgesics that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. This list was last comprehensively updated in June 2017. It is likely to become outdated ...
In exchange for giving up ownership of drug manufacturer Purdue Pharma and for contributing up to $6 billion to fight the crisis, members of the wealthy Sackler family would be exempt from any ...